Skip to main content
. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091

Table 4.

Complications and treatments of patients with coronavirus disease 2019 who died and recovered patients. Values are numbers (percentages)

Total (n=274) Deaths (n=113) Recovered patients (n=161)
Complications
Acute respiratory distress syndrome 196 (72) 113 (100) 83 (52)
Type I respiratory failure 18/67 (27) 18/35 (51) 0/32 (0)
Acute cardiac injury 89/203 (44) 72/94 (77) 18/109 (17)
 With history of hypertension or cardiovascular disease 47/77 (61) 37/48 (77) 11/30 (37)
 Without history of hypertension or cardiovascular disease 42/126 (33) 35/46 (76) 7/80 (9)
Heart failure 43/176 (24) 41/83 (49) 3/94 (3)
 With history of hypertension or cardiovascular disease 23/67 (34) 21/42 (50) 2/25 (8)
 Without history of hypertension or cardiovascular disease 21/109 (19) 20/41 (49) 1/68 (1)
Hypoxic encephalopathy 24 (9) 23 (20) 1 (1)
Sepsis 179 (65) 113 (100) 66 (41)
Acidosis 8/67 (12) 5/35 (14) 3/32 (9)
Alkalosis 19/67 (28) 14/35 (40) 5/32 (16)
Acute kidney injury 29 (11) 28 (25) 1 (1)
Disseminated intravascular coagulation 21 (8) 19 (17) 2 (1)
Hyperkalaemia 62 (23) 42 (37) 22 (14)
Shock 46 (17) 46 (41) 0 (0)
Acute liver injury 13 (5) 10 (9) 3 (2)
Gastrointestinal bleeding 1 (<1) 1 (1) 0 (0)
Treatment
Antiviral therapy 236 (86) 89 (79) 147 (91)
Glucocorticoid therapy 217 (79) 99 (88) 118 (73)
Antibiotics 249 (91) 105 (93) 144 (89)
Intravenous immunoglobulin therapy 54 (20) 44 (39) 59 (37)
Interferon inhalation 89 (32) 25 (22) 64 (40)
Oxygen treatment 251 (92) 113 (100) 138 (86)
 High flow nasal cannula 85 (31) 77 (68) 8 (5)
 Mechanical ventilation 119 (43) 93 (82) 26 (16)
  Non-invasive 102 (37) 76 (67) 26 (16)
  Invasive 17 (6) 17 (15) 0 (0)
Continuous renal replacement therapy 3 (1) 3 (3) 0 (0)
Extracorporeal membrane oxygenation 1 (<1) 1 (1) 0 (0)